Rosiglitazone

Rosiglitazone

SCHEMBL4889277

CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=P(O)(O)O

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARG

The experimentally established mechanism targets of Rosiglitazone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PPARG known ✓ P37231 15/20 0.92
RXRA P19793 2/20 0.81
RARG P13631 1/20 0.81
PPARA Q07869 2/20 0.59
FFAR1 O14842 4/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
PKM P14618 1/20 0.51
HTT P42858 1/20 0.51
CYP3A4 P08684 1/20 0.48
ESR1 P03372 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rosiglitazone SCHEMBL4897990 0.99 PPARG (0.91) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL29530259 0.96 PPARG (1.00) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL11957687 0.96 PPARG (1.00) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL5169 0.96 PPARG (1.00) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL7052472 0.96 PPARG (1.00) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL2355017 0.96 PPARG (1.00) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL1489117 0.95 PPARG (0.98) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL3377103 0.95 PPARG (0.98) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL5468691 0.95 PPARG (0.98) PPARGRXRARARGPPARAFFAR1
Rosiglitazone SCHEMBL3375739 0.95 PPARG (0.98) PPARGRXRARARGPPARAFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319024-A1 Rosiglitazone Phosphate and Polymorphic Forms GREIL JULIA 2008-12-25 US claimed
EP-1735291-A2 ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS Sandoz AG (CH) 2006-12-27 EP claimed
WO-2005080358-A2 ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS SANDOZ AG (CH) 2005-09-01 WO claimed
US-20080319024-A1 Rosiglitazone Phosphate and Polymorphic Forms GREIL JULIA 2008-12-25 US disclosed
US-20080319024-A1 Rosiglitazone Phosphate and Polymorphic Forms GREIL JULIA 2008-12-25 US disclosed
CN-1964966-A Rosiglitazone phosphate and polymorphic forms SANDOZ AG (CH) 2007-05-16 CN disclosed
CN-1964966-A Rosiglitazone phosphate and polymorphic forms SANDOZ AG (CH) 2007-05-16 CN disclosed
CN-1964966-A Rosiglitazone phosphate and polymorphic forms SANDOZ AG (CH) 2007-05-16 CN disclosed
WO-2005080358-A3 ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS SANDOZ AG (CH) 2006-12-28 WO disclosed
EP-1735291-A2 ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS Sandoz AG (CH) 2006-12-27 EP disclosed
EP-1735291-A2 ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS Sandoz AG (CH) 2006-12-27 EP disclosed
WO-2005080358-A2 ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS SANDOZ AG (CH) 2005-09-01 WO disclosed
WO-2005080358-A2 ROSIGLITAZONE PHOSPHATE AND POLYMORPHIC FORMS SANDOZ AG (CH) 2005-09-01 WO disclosed